p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells
By: Xinyu Wu, Daixing Zhong, Bin Lin, Wenliang Zhai, Zhenqi Ding and Jin Wu
Open Access
|Feb 2013References
- 1. Warmke J, Drysdale R, Ganetzky B. A distinct potassium channel polypeptide encoded by the Drosophila eag locus.1991;1560-2.
- 2. Warmke JW, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals.1994;3438-42.
- 3. Martin S, Lino de Oliveira C, Mello de Queiroz F, Pardo LA, Stühmer W, Del Bel E. Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain.2008;833-44.
- 4. Mello de Queiroz F, Suarez-Kurtz G, Stühmer W, Pardo LA. Ether à go-go potassium channel expression in soft tissue sarcoma patients.2006;42
- 5. Hemmerlein B, Weseloh RM, Mello de Queiroz F, Knötgen H, Sánchez A, Rubio ME, et al. Overexpression of Eag1 potassium channels in clinical tumours.2006;41
- 6. Downie BR, Sánchez A, Knötgen H, Contreras-Jurado C, Gymnopoulos M, Weber C, et al. Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.2008;36234-40.
- 7. Restrepo-Angulo I, Sánchez-Torres C, Camacho J. Human EAG1 potassium channels in the epithelial-to-mesenchymal transition in lung cancer cells.2011;1265-70.
- 8. Weber C, Mello de Queiroz F, Downie BR, Suckow A, Stühmer W, Pardo LA. Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference.2006;13030-7.
- 9. García-Ferreiro RE, Kerschensteiner D, Major F, Monje F, Stühmer W, Pardo LA. Mechanism of block of hEag1 K+ channels by imipramine and astemizole.2004;301-7.
- 10. Ding XW, Luo HS, Jin X, Yan JJ, Ai YW. Aberrant expression of Eag1 potassium channels in gastric cancer patients and cell lines.2007;345-50.
- 11. Camacho J. Ether à go-go potassium channels and cancer.2006;1-9.
- 12. Pardo LA, Sühmer W. Eag1 as cancer target.2008;837-43.
- 13. Agarwal JR, Griesinger F, Stühmer W, Pardo LA. The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia.2010;18
- 14. Rastegar F, Gao JL, Shenaq D, Luo Q, Shi Q, Kim SH, et al. Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.2010;e14182.
- 15. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art.2006;423-6.
- 16. Kachanov DY, Dobrenkov KV, ShamanskayaTV, Abdullaev RT, Inushkina EV, Savkova RF et al. Solid tumors in young children in Moscow Region of Russian Federation.2008;39-44.
- 17. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.2002;776-90.
- 18. Fagioli F, Aglietta M, Tienghi A, Ferrari S, Brach del Prever A,Vassallo E, et al. High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study.2002;2150-6.
- 19. Marina N, Gorlick R. Immune approaches to treating osteosarcoma.2009;981-3.
- 20. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses.1998;2509-14.
- 21. Gao YS, Mei J, Tong TL, Hu M, Xue HM, Cai XS. Inhibitory effects of VEGFsiRNA mediated by adenovirus on osteosarcoma-bearing nude mice.2009;243-7.
- 22. Hegle AP, Marble DD, Wilson GF. A voltage-driven switch for ion-independent signaling by ether-a-go-go K+ channels.. 2006;2886-91.
- 23. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development.2009;537-49.
- 24. Rebersek M, Boc M, Cerkovnik P, Benedik J, Hlebanja Z, Volk N, et al. Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis.2011;285-91.
- 25. Bulavin DV, Kovalsky O, Hollander MC, Fornace AJ Jr. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.2003;3859-71.
- 26. Cardaci S, Filomeni G, Rotilio G, Ciriolo MR. p38(MAPK)/p53 signalling axis mediates neuronal apoptosis in response to tetrahydrobiopterin-induced oxidative stress and glucose uptake inhibition: implication for neurodegeneration.2010;439-51.
- 27. Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, Toillon RA, Delcourt P, N Prevarskaya. Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel.2001;345-56.
- 28. Asher V, Warren A, Shaw R, Sowter H, Bali A, Khan R. The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line.2011;6
- 29. Gavrilova-Ruch O, Schönherr K, Gessner G, Schönherr R, Klapperstück T, Wohlrab W, et al. Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells.2002;137-49.
- 30. Platanias LC. Map kinase signaling pathways and hematologic malignancies.2003;4667-79.
- 31. Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y, et al.
- Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.2003;19245-56.
- 32. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer.2005;322-7.
- 33. Kraunz KS, Nelson HH, Liu M, Wiencke JK, Kelsey KT. Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer.2005;949-52.
- 34. Sasaki K, Hitora T, Nakamura O, Kono R, Yamamoto T. The role of MAPK pathway in bone and soft tissue tumors.2011;549-53.
- 35. Shimo T, Matsumura S, Ibaragi S, Isowa S, Kishimoto K, Mese H, et al. Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells.2007;103-11.
- 36. Asher V, Sowter H, Shaw R, Bali A, Khan R. Eag and HERG potassium channels as novel therapeutic targets in cancer.2010;113
- 37. Lin H, Li Z, Chen C, Luo X, Xiao J, Dong D, et al. Transcriptional and posttranscriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel.2011;e20362.
Language: English
Page range: 42 - 49
Published on: Feb 1, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2013 Xinyu Wu, Daixing Zhong, Bin Lin, Wenliang Zhai, Zhenqi Ding, Jin Wu, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.